Literature DB >> 19373049

Prolonged glucocorticoid treatment in acute respiratory distress syndrome: Evidence supporting effectiveness and safety.

G Umberto Meduri, Paul E Marik, Djillali Annane.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19373049     DOI： 10.1097/CCM.0b013e31819d2b43

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  9 in total

Review 1.  Corticosteroid therapy in acute respiratory distress syndrome.

Authors:  François Lamontagne; Roy Brower; Maureen Meade
Journal:  CMAJ       Date:  2012-11-12       Impact factor: 8.262

Review 2.  An overview of preoperative glucose evaluation, management, and perioperative impact.

Authors:  Ann M Sheehy; Robert A Gabbay
Journal:  J Diabetes Sci Technol       Date:  2009-11-01

3.  Pneumonia due to aspiration of povidine iodine after preoperative disinfection of the oral cavity.

Authors:  Takashi Hitosugi; Masanori Tsukamoto; Takeshi Yokoyama
Journal:  Oral Maxillofac Surg       Date:  2019-11-01

4.  Prone Positioning and Intravenous Zanamivir may Represent Effective Alternatives for Patients with Severe ARDS Virus A (H1N1) Related Pneumonia in Hospitals with no Access to ECMO.

Authors:  Giuseppe Gristina; Giuseppe Nardi; Daniela Orazi; Francesco Nicola Lauria; Maria Beatrice Valli; Eleonora Lalle; Stefano Menzo; Luigi Riccioni; Maria Pia Camporiondo
Journal:  Crit Care Res Pract       Date:  2010-12-15

5.  Pneumonia due to aspiration of povidine iodine after induction of general anesthesia -A case report-.

Authors:  Tae Hun An; Byung Ryang Ahn
Journal:  Korean J Anesthesiol       Date:  2011-09-23

6.  Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: a need for early immune-modulators for severe cases.

Authors:  Kyung-Yil Lee; Jung-Woo Rhim; Jin-Han Kang
Journal:  Med Hypotheses       Date:  2010-09-06       Impact factor: 1.538

7.  Major candidate variables to guide personalised treatment with steroids in critically ill patients with COVID-19: CIBERESUCICOVID study.

Authors:  Antoni Torres; Ana Motos; Catia Cillóniz; Adrián Ceccato; Laia Fernández-Barat; Albert Gabarrús; Jesús Bermejo-Martin; Ricard Ferrer; Jordi Riera; Raquel Pérez-Arnal; Dario García-Gasulla; Oscar Peñuelas; José Ángel Lorente; David de Gonzalo-Calvo; Raquel Almansa; Rosario Menéndez; Andrea Palomeque; Rosario Amaya Villar; José M Añón; Ana Balan Mariño; Carme Barberà; José Barberán; Aaron Blandino Ortiz; Maria Victoria Boado; Elena Bustamante-Munguira; Jesús Caballero; María Luisa Cantón-Bulnes; Cristina Carbajales Pérez; Nieves Carbonell; Mercedes Catalán-González; Raul de Frutos; Nieves Franco; Cristóbal Galbán; Víctor D Gumucio-Sanguino; Maria Del Carmen de la Torre; Emili Díaz; Ángel Estella; Elena Gallego; José Luis García Garmendia; José M Gómez; Arturo Huerta; Ruth Noemí Jorge García; Ana Loza-Vázquez; Judith Marin-Corral; María Cruz Martin Delgado; Amalia Martínez de la Gándara; Ignacio Martínez Varela; Juan López Messa; Guillermo M Albaiceta; Maite Nieto; Mariana Andrea Novo; Yhivian Peñasco; Felipe Pérez-García; Juan Carlos Pozo-Laderas; Pilar Ricart; Victor Sagredo; Angel Sánchez-Miralles; Susana Sancho Chinesta; Mireia Serra-Fortuny; Lorenzo Socias; Jordi Solé-Violan; Fernando Suarez-Sipmann; Luis Tamayo Lomas; José Trenado; Alejandro Úbeda; Luis Jorge Valdivia; Pablo Vidal; Ferran Barbé
Journal:  Intensive Care Med       Date:  2022-06-21       Impact factor: 41.787

8.  Do corticosteroids reduce the mortality of influenza A (H1N1) infection? A meta-analysis.

Authors:  Yi Zhang; Wenjie Sun; Erik R Svendsen; Song Tang; Raina C MacIntyre; Peng Yang; Daitao Zhang; Quanyi Wang
Journal:  Crit Care       Date:  2015-02-20       Impact factor: 19.334

9.  H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment.

Authors:  Adolfo Maximo Quispe-Laime; Jonas Daniel Bracco; Patricia Alejandra Barberio; Claudio German Campagne; Verónica Edith Rolfo; Reba Umberger; Gianfranco Umberto Meduri
Journal:  Intensive Care Med       Date:  2009-11-19       Impact factor: 17.440
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.